Introduction
Life is a balancing act. Good and evil, right and wrong, production and destruction are in opposition, at the social level. And at the biological level, networks of regulation interact to maintain the metabolic balance and offset proliferation with differentiation, inflammation with anti-inflammatory mechanisms, etc. In a word: homeostasis. The balance between opposing forces is part of the underlying biological design, a fundamental theme in cell and organism.
This theme is particularly evident in the cancer field, where genes encoding tumor-suppressor proteins are at least as important in tumor progression as those (i.e., oncogenes) with tumor-promoting activity. Losses of tumor-suppressor activity, as well as the activation of oncogenes, are driven by genomic instability leading to mutations, large deletions, rearrangements, and aneuploidy (1) .
These progressive genomic changes include effects on cells that regulate cell proliferation and differentiation, enmeshing cancer onset and progression with systemic aging and with cellular senescence and immortalization. (Table 1) .
The lines infected with K-ras were shown to contain the phosphorylated form of the encoded p21 protein, demonstrating expression of the viral gene. The FSVK and Va2k cells also expressed T-antigen as shown by immunocytofluorescence.
Thus, when normal human fibroblasts, FS-2 cells, are infected with the Kirsten ras virus, they do not make tumors, despite expressing the viral ras gene. In FS-2 cells expressing both T-antigen and viral K-ras protein, i.e., FSVK cells, the tumorigenic effect of the viral ras was seen as the initial growth of small tumors in the nude mouse assay, subsequently blocked by putative senescence gene-encoded proteins. The Va2 cells, the positive controls, produced tumors on schedule following infection with the K-ras virus.
These studies provide a clear experimental dichotomy between immortalization and tumor growth. These experiments distinguish the differential effects of the two processes and show that both are required for effective tumor formation. Immortalization is shown to play a distinctive and essential role in tumorigenesis. Contrariwise, senescence is shown to block tumor formation (6) .
Previous studies with HPV (7) have demonstrated the existence of many types; so far about 65 have been recognized on the basis of differences in DNA sequence, measured by cross-hybridization. Only a few of these types have been associated with carcinomas, either genital or oral. The virus exhibits high host specificity for squamous epithelium. No reports are known of HPV in glandular epithelium.
Human papilloma virus has proven very difficult to grow in human tissues in the laboratory, but recently, with the availability of plasmids containing the full viral genome, linearized and unable to replicate autonomously, it has become possible to study HPV by transfection. Encouraged by positive results of other investigators with keratinocytes, the known cellular hosts of HPV (8-11), we used the same plasmids, containing HPV 16 and HPV 18, frequently associated with cervical carcinoma, to transfect normal human mammary epithelial cells growing in our novel DFCI-1 (Dana-Farber Cancer Institute) medium (12) . This medium supports the growth of both normal and tumor-derived mammary epithelial cells and was therefore considered the medium of choice for selection of putative immortalized cells, which would have unknown growth factor requirements. 76N cells, previously described (5), were transfected by the calcium phosphate procedure with either HPV 16 or 18, as well as pSVneo used for selection. Our recovery was about i0-5 neo-resistant colonies, all of which when tested contained the HPV plasmid. Several individual clones as well as pools of colonies from single plates of both HPV types were subsequently shown to contain one or multiple copies of the HPV genome, integrated into cellular DNA, with no evidence of free episomes.
Chromosome counts and karyotypic analysis revealed that some clones were hypodiploid and showed minimal chromosome rearrangements, whereas several others were aneuploid and rearranged, much as has been reported for HPV-transfected keratinocytes (13) . The hypodiploid clones also contained on average a single copy of HPV per cell.
The expression of HPV-encoded protein E7 was demonstrated with the use of antibody preparations against HPV 16/E7, a gift from D. Galloway and J. McDougall, and against HPV 18/E7, from L. Gissman and H. zur Hausen. The proteins were expressed in clonally isolated as well as pooled samples (12) .
The changes in growth factor requirements were of particular interest. Although the normal 76N cells used in these experiments grow well in DFCI-1 medium, they do not form colonies on plastic. The cells will grow, but at a slower rate, on D2 medium, which lacks fetal calf serum and bovine pituitary extract. The HPV transfectants grow at the same rate on both of these media and plate with about 15% plating efficiency on each of them. In addition, the transfectants grow and plate on a medium, D3 + epidermal growth factor (EGF), in which the supplemental growth factors insulin, hydrocortisone, triiodothyronine, and cholera toxin have been removed.
Finally, with respect to immortalization and tumorforming ability, the parental 76N cells senesce after 15 to 20 passages in culture, whereas all of the tested clonal and pooled transfectants have grown 200 
